
Shangbay Capital
North America, California, United States, Palo Alto
Description
Best-in-class investments mainly in the U.S. medical devices technology, as well as biotech, and mobile healthcare sectors through early sta
Investor Profile
Shangbay Capital has made 41 investments, with 4 in the past 12 months and 27% as lead.
Stage Focus
- Series A (41%)
- Series B (24%)
- Series Unknown (10%)
- Series D (7%)
- Series C (7%)
- Seed (5%)
- Series E (2%)
- Private Equity (2%)
Country Focus
- United States (93%)
- Canada (5%)
- China (2%)
Industry Focus
- Health Care
- Medical Device
- Medical
- Biotechnology
- Therapeutics
- Biopharma
- Health Diagnostics
- Genetics
- Neuroscience
- Artificial Intelligence (Ai)
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.